MODDERN

Personalized medicine proponents have revived legislation seeking to improve the reimbursement system for diagnostics and to incentivize the development of companion tests that pick out best responders to drugs.

Originally published Oct. 1.
A new bill strongly supported within the diagnostics industry could put pressure on the Centers for Medicare & Medicaid Services to alter its procedures for setting reimbursement rates for molecular diagnostics.

Representative Leonard Lance (R-NJ) recently introduced a bill that includes proposals for enhancing the reimbursement system for diagnostic tests, as well as incentives for pharmaceutical firms to revive unapproved drugs in their pipelines as treatments for unmet medical need.

A fire at a Manchester hospital may have destroyed lab equipment and data, the Guardian reports.

Researchers generate a genetic database from skeletal remains from the 1845 Franklin Expedition to the Arctic, Live Science reports.

Researchers in China have begun another trial using CRISPR/Cas9 approaches in cancer patients, according to the Wall Street Journal.

In Science this week: human DNA found in sediments from archeological sites lacking bones, and more.